Technology Review - Published By MIT
Advertisement
TO READ THIS STORY - you must have a paid subscription to Technology Review OR you can purchase special archive reading credits here. Choose from these great offers below.
I'm a paid subscriber please
log me in
I want to purchase this article for
only $1.99
(requires login)
I want to purchase five articles for
only $7.99
(requires login)
I want to buy
1 Year TOTAL Access for
only $24.95
(requires login)

Please note: Click here if you are currently a Technology Review print or digital subscriber and do not have access to this article.

November 2003

Booster Shot against Cancer

Cautious optimism about the latest efforts to enlist the immune system.

By Corie Lok

In the war on cancer, researchers have long struggled to recruit the body's immune system to attack tumors while leaving healthy cells alone. This strategy-basically that of vaccination-would offer a huge improvement over existing treatments such as chemotherapy and radiation, which kill healthy and diseased cells indiscriminately and carry harsh side effects. But repeated attempts to find a cancer vaccine have failed, largely because scientists have had a crude understanding of the molecular mechanics of the immune system and cancer cells.

Select from the choices above
to read the entire article.


Log In

Forgot your password?     Register »
Advertisement

Videos

Microsoft's Many Multitouch Mice
Advertisement
Advertisement
Advertisement
Subscribe to Technology Review's daily e-mail update. Enter your e-mail address

TECHNOLOGY RESOURCES

More Technology News from Forbes

Advertisement
MIT Massachusetts Institute of Technology © 2009 Technology Review. All Rights Reserved.